catalpol has been researched along with Hyperglycemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, C; Cui, Y; Guan, Y; Liu, C; Song, L; Wang, J; Wu, X; Zhang, Y | 1 |
| Fang, WJ; Hou, SW; Lin, CM; Pan, CM; Shyu, KG; Wang, BW | 1 |
2 other study(ies) available for catalpol and Hyperglycemia
| Article | Year |
|---|---|
Catalpol Weakens Depressive-like Behavior in Mice with Streptozotocin-induced Hyperglycemia via PI3K/AKT/Nrf2/HO-1 Signaling Pathway.
Topics: Animals; Heme Oxygenase-1; Humans; Hyperglycemia; Iridoid Glucosides; Mice; NF-E2-Related Factor 2; Oxidative Stress; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction; Streptozocin | 2021 |
Catalpol Ameliorates Neointimal Hyperplasia in Diabetic Rats.
Topics: Animals; Carotid Arteries; Carotid Artery Injuries; Chemokine CCL2; Diabetes Mellitus, Experimental; Disease Models, Animal; Hyperglycemia; Hyperplasia; Hypoglycemic Agents; Iridoid Glucosides; Male; Myocardial Ischemia; Neointima; Rats; Rats, Wistar; Rehmannia; Streptozocin | 2019 |